Cancer Vaccine
Future directions for field of oncolytic virotherapy reviewed
Published in Vaccine Weekly, October 13th, 2004
According to a study from the United States, "Oncolytic virotherapy is an emerging biotherapeutic platform based on genetic engineering of viruses capable of selectively infecting and replicating within cancer cells. Such viruses have been found to be both safe and to produce antitumor effects in a number of Phase I and II clinical trials. Early work in this field has been pioneered with strains of adenovirus which, although well suited to gene therapy approaches, have displayed certain limitations in their ability to directly...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2004-10-13)
More Articles from Vaccine Weekly
- AIDS/HIV Vaccine
Correlates of immune protection in HIV-1 infection reviewed - Filariasis Vaccine
Subtractive screening identifies Brugia malayi vaccine candidates - Immune Responses
Salmonella vaccine elicit immunity against foreign antigen in neonates - Malaria Vaccine
Long-term T-cell responses induced by Plasmodium peptides - AIDS/HIV Vaccine
Breakthrough infections occur during HIV-1 vaccine trials - AIDS/HIV Vaccine
Development of AIDS vaccine from South African perspective presented - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
